Company Description
Natural Alternatives International, Inc. engages in formulating, manufacturing, and marketing nutritional supplements in the United States and internationally.
It operates through two segments: Private-Label Contract Manufacturing, and Patent and Trademark Licensing.
The company offers private-label contract manufacturing services to companies that market and distribute vitamins, minerals, herbal, and other nutritional supplements, as well as other health care products.
It also provides strategic partnering services, such as customized product formulation, clinical study design and support, manufacturing, marketing support, international regulatory and label law compliance, international product registration, packaging in multiple formats and labeling design, scientific research, proprietary ingredients, customer-specific nutritional product formulation, product testing and evaluation, marketing management, packaging and delivery system design, regulatory review, and international product registration assistance.
In addition, the company sells beta-alanine ingredient under the CarnoSyn and SR CarnoSyn names. The company manufactures products in various forms, including capsules, tablets, chewable wafers, and powders.
Its private-label contract manufacturing customers include companies that market nutritional supplements through direct sales marketing channels, direct to consumer e-commerce channels, and retail stores.
Natural Alternatives International, Inc. was founded in 1980 and is headquartered in Carlsbad, California.
| Country | United States |
| Founded | 1980 |
| IPO Date | Mar 13, 1987 |
| Industry | Packaged Foods |
| Sector | Consumer Staples |
| Employees | 296 |
| CEO | Mark LeDoux |
Contact Details
Address: 1535 Faraday Avenue Carlsbad, California 92008 United States | |
| Phone | 760 744 7700 |
| Website | nai-online.com |
Stock Details
| Ticker Symbol | NAII |
| Exchange | NASDAQ |
| Fiscal Year | July - June |
| Reporting Currency | USD |
| CIK Code | 0000787253 |
| CUSIP Number | 638842302 |
| ISIN Number | US6388423021 |
| Employer ID | 84-1007839 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Mark A. LeDoux J.D. | Chairman of the Board and Chief Executive Officer |
| Shane Conti | Vice President of Global Sales |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 10, 2024 | 8-K | Current Report |
| Nov 13, 2024 | 10-Q | Quarterly Report |
| Nov 13, 2024 | 10-Q | Quarterly Report |
| Oct 23, 2024 | DEF 14A | Other definitive proxy statements |
| Sep 27, 2024 | 10-K | Annual Report |
| May 14, 2024 | 10-Q | Quarterly Report |
| Feb 13, 2024 | 10-Q | Quarterly Report |
| Feb 13, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 9, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Feb 5, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |